journal article·2020-04-01

Nanoporosity Stimulates Cell Spreading and Focal Adhesion Formation in Cells with Mutated Paxillin

Dainelys Guadarrama Bello, Aurélien Fouillen, Antonella Badia, Antonio Nanci

ACS Applied Materials & Interfaces· Volume 12· Issue 13
Publisher page

Abstract

We have evaluated the response to nanotopography of CHO-K1 cells that express wild-type paxillin or paxillin with mutations at serine 273 that inhibit phosphorylation. Cells were grown on nanoporous and polished titanium surfaces. With all cell types, immunofluorescence showed that adhesion and spreading were minimally affected on the treated surface and that the actin filaments were more abundant and well-aligned. Scanning electron microscopy revealed changes in cell shape and abundant filopodia with lateral nanoprotrusions in response to nanoporosity. Gene expression of proteins associated with cellular adhesion and protrusions was significantly increased on the nanoporous surface regardless of the cell type. In particular, α-actinin, Rac1, Cdc42, and ITGα1 were upregulated in S273 cells with alanine substitutions, whereas FAK, Pxn, and Src were downregulated, leading to improved focal adhesion formation. These findings suggest that the surface nanoporosity can "compensate for" the genetic mutations that affect the biomechanical relationship of cells to surfaces.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cellular Mechanics and Interactions · Cell Adhesion Molecules Research · Force Microscopy Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory for the Study of Calcified Tissues and Biomaterials, Department of Stomatology, Faculty of Dentistry, Université de Montréal, Montréal, Québec H3C3J7, Canada

Department of Chemistry, Faculty of Arts and Sciences, Université de Montréal, Québec H3C3J7, Canada

Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal, Québec H3C3J7, Canada

Funding

Canadian Institutes of Health Research · Fonds de Recherche du Québec - Santé · Natural Sciences and Engineering Research Council of Canada

References (48)

Show source-provided references
1. Kuhn L. T. · 2005 · 25510.1016/B978-0-12-238662-6.50008-2 ↗
2. 10.1016/j.biomaterials.2009.10.03710.1016/j.biomaterials.2009.10.037 ↗
3. 10.1016/j.nantod.2014.12.00210.1016/j.nantod.2014.12.002 ↗
4. 10.1038/nmat398010.1038/nmat3980 ↗
5. 10.1002/jcb.2468810.1002/jcb.24688 ↗
6. 10.1016/j.actbio.2014.03.03710.1016/j.actbio.2014.03.037 ↗
7. 10.1016/j.biomaterials.2011.01.02910.1016/j.biomaterials.2011.01.029 ↗
8. 10.1002/jbm.a.3095510.1002/jbm.a.30955 ↗
9. 10.1111/j.1600-0501.2007.01344.x10.1111/j.1600-0501.2007.01344.x ↗
10. 10.1038/ncb109410.1038/ncb1094 ↗
11. 10.4161/cam.1.1.408110.4161/cam.1.1.4081 ↗
12. 10.1242/jcs.03047810.1242/jcs.030478 ↗
13. 10.1016/j.ejcb.2014.07.00210.1016/j.ejcb.2014.07.002 ↗
14. 10.1091/mbc.9.7.180310.1091/mbc.9.7.1803 ↗
15. 10.1186/s13045-017-0418-y10.1186/s13045-017-0418-y ↗
16. 10.1038/3504665910.1038/35046659 ↗
17. 10.1016/j.bpj.2010.12.371910.1016/j.bpj.2010.12.3719 ↗
18. 10.1038/137010.1038/1370 ↗
19. 10.1083/jcb.135.4.110910.1083/jcb.135.4.1109 ↗
20. 10.1083/jcb.20050907510.1083/jcb.200509075 ↗
21. 10.1016/j.colsurfb.2017.11.05110.1016/j.colsurfb.2017.11.051 ↗
22. 10.1016/j.actbio.2017.07.02210.1016/j.actbio.2017.07.022 ↗
23. 10.1038/onc.2012.48810.1038/onc.2012.488 ↗
24. 10.1016/j.susc.2006.07.05310.1016/j.susc.2006.07.053 ↗
25. 10.1371/journal.pone.002830310.1371/journal.pone.0028303 ↗
26. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗
27. 10.1016/j.ceb.2011.11.00110.1016/j.ceb.2011.11.001 ↗
28. 10.1242/jcs.0331410.1242/jcs.03314 ↗
29. 10.1242/jcs.0256310.1242/jcs.02563 ↗
30. 10.1038/s41598-019-47722-310.1038/s41598-019-47722-3 ↗
31. 10.1016/j.actbio.2010.04.00110.1016/j.actbio.2010.04.001 ↗
32. 10.1016/j.stem.2010.06.01710.1016/j.stem.2010.06.017 ↗
33. 10.1038/nmat285510.1038/nmat2855 ↗
34. 10.1126/science.122170810.1126/science.1221708 ↗
35. 10.1016/j.actbio.2015.11.02710.1016/j.actbio.2015.11.027 ↗
36. 10.1016/j.nano.2018.07.00210.1016/j.nano.2018.07.002 ↗
37. 10.1016/j.colsurfb.2010.12.03210.1016/j.colsurfb.2010.12.032 ↗
38. 10.1016/j.actbio.2019.03.05410.1016/j.actbio.2019.03.054 ↗
39. 10.1002/(SICI)1097-4636(199805)40:2<324::AID-JBM18>3.0.CO;2-L10.1002/(SICI)1097-4636(199805)40:2<324::AID-JBM18>3.0.CO;2-L ↗
40. 10.1083/jcb.20151003610.1083/jcb.201510036 ↗
41. 10.1242/jcs.01804410.1242/jcs.018044 ↗
42. 10.1038/nrm240610.1038/nrm2406 ↗
43. 10.2147/IJN.S7162210.2147/IJN.S71622 ↗
44. 10.2147/IJN.S6133310.2147/IJN.S61333 ↗
45. 10.1021/acs.accounts.8b0060410.1021/acs.accounts.8b00604 ↗
46. 10.1091/mbc.e06-03-020710.1091/mbc.e06-03-0207 ↗
47. 10.1016/S0955-0674(00)00255-610.1016/S0955-0674(00)00255-6 ↗
48. 10.1038/nrm154910.1038/nrm1549 ↗